{"id":26024,"date":"2022-02-25T11:56:18","date_gmt":"2022-02-25T16:56:18","guid":{"rendered":"https:\/\/www.ncqa.org\/?page_id=26024"},"modified":"2025-09-29T12:33:59","modified_gmt":"2025-09-29T16:33:59","slug":"data-errata-for-hedis-data-submission","status":"publish","type":"page","link":"https:\/\/www.ncqa.org\/hedis\/data-submission\/data-errata-for-hedis-data-submission\/","title":{"rendered":"Data Errata for HEDIS Data Submission"},"content":{"rendered":"

The data errata is a list of self-reported errors that were identified by organizations after the HEDIS data re-submission deadline of June 30th. Per NCQA’s HEDIS Volume 2, “organizations must immediately report any error in a measure rate or in its component (in any previous submission, regardless of timing) that is >5% higher or lower than what was reported originally.”<\/p>\n

Errors are reviewed by NCQA to assess the impact to NCQA products and programs, including but not limited to Health Plan Ratings, Quality Compass and Accreditation. If the impact is determined to be significant, NCQA will notify customers via the data errata page and potential other avenues of communication such as the Quality Compass homepage.<\/p>\n

Depending on the significance and scope of the error, NCQA takes the necessary actions. This data errata page lists the reported errors so that users of NCQA\u2019s programs and products can see the description and resolution and consider any implications to their use of the data.<\/p>\n

Note: The data errors listed below reflect corrections reported within the last four measurement years only.<\/em><\/p>\n

\n \n \n \n \n \n \n \n \n \n \n <\/colgroup>\n \n\n \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
Date Reported<\/th>HEDIS Measurement Year<\/th>Org ID<\/th>Organization Name<\/th>Product Lines<\/th>Measure Name<\/th>Description of Error<\/th>Resolution<\/th><\/tr>\n<\/thead>\n
11\/12\/2025<\/td>2024<\/td>13979<\/td>Blue Cross and Blue Shield of Massachusetts, Inc.<\/td>Commercial<\/td>Kidney Health Evaluation for Patients With Diabetes (KED)<\/td>Erroneous logic resulted in over reporting of performance<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
11\/12\/2025<\/td>2024<\/td>174<\/td>Blue Cross and Blue Shield of Massachusetts, Inc.<\/td>Commercial<\/td>Kidney Health Evaluation for Patients With Diabetes (KED)<\/td>Erroneous logic resulted in over reporting of performance<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
11\/12\/25<\/td>2024<\/td>13979<\/td>Blue Cross and Blue Shield of Massachusetts, Inc.<\/td>Exchange<\/td>Kidney Health Evaluation for Patients With Diabetes (KED)<\/td>Erroneous logic resulted in over reporting of performance<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
6\/9\/2025<\/td>2023<\/td>132<\/td>Kaiser Foundation Health Plan Inc. - Southern California<\/td>Exchange<\/td>INR - International Normalized Ratio Monitoring for Individuals on Warfarin<\/td>Erroneous logic resulted in over reporting of performance<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
5\/17\/2025<\/td>2023<\/td>192<\/td>Health New England<\/td>Exchange<\/td>Multiple Measure Indicators were impacted by this data error.<\/td>Erroneous logic resulted in a combination of overreported and underreported performance rates.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
5\/16\/2025<\/td>2023<\/td>192<\/td>Health New England<\/td>Commercial<\/td>Multiple Measure Indicators were impacted by this data error.<\/td>Erroneous logic resulted in a combination of overreported and underreported performance rates.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
4\/8\/2025<\/td>2023<\/td>284953<\/td>Blue Cross and Blue Shield of Montana, a Division of Health Care Service Corporation (FEP)<\/td>Commercial<\/td>Statin Therapy for Patients With Diabetes - Received Statin Therapy (SPD)<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
3\/12\/2025<\/td>2023<\/td>Multiple OrgIDs<\/td>Multiple Orgs in the Aetna Family were impacted by this data error<\/td>Medicare<\/td>Follow-Up After Emergency Department Visit for People With Multiple High-Risk Chronic Conditions<\/td>Erroneous logic resulted in a combination of overreported and underreported performance rates.<\/td>Due to assessed level of impact and timing of notification, no product updates were made.<\/td> <\/tr>\n
2\/27\/2025<\/td>2023<\/td>Multiple OrgIDs<\/td>Multiple Orgs in the Aetna Family were impacted by this data error<\/td>Medicare, Exchange<\/td>Plan All-Cause Readmissions<\/td>Erroneous logic resulted in a combination of overreported and underreported performance rates.<\/td>Due to assessed level of impact and timing of notification, no product updates were made.<\/td> <\/tr>\n
6\/13\/2024<\/td>2022<\/td>70731<\/td>Sutter Health Plus<\/td>Commercial <\/td>FUH- Follow-Up After Hospitalization For Mental Illness - 7 days<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
6\/13\/2024<\/td>2022<\/td>70731<\/td>Sutter Health Plus<\/td>Commercial <\/td>FUH - Follow-Up After Hospitalization For Mental Illness - 30 days<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
6\/13\/2024<\/td>2022<\/td>70731<\/td>Sutter Health Plus<\/td>Commercial <\/td>FUA - Follow-Up After Emergency Department Visit for Substance Use - 7 days<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
6\/13\/2024<\/td>2022<\/td>70731<\/td>Sutter Health Plus<\/td>Commercial <\/td>FUA - Follow-Up After Emergency Department Visit for Substance Use - 30 days<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
6\/13\/2024<\/td>2022<\/td>70731<\/td>Sutter Health Plus<\/td>Commercial <\/td>FUM - Follow-Up After Emergency Department Visit for Mental Illness - 7 days<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
6\/13\/2024<\/td>2022<\/td>70731<\/td>Sutter Health Plus<\/td>Commercial <\/td>FUM - Follow-Up After Emergency Department Visit for Mental Illness - 30 days<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
6\/13\/2024<\/td>2022<\/td>70731<\/td>Sutter Health Plus<\/td>Commercial <\/td>PCE - Pharmacotherapy Management of COPD Exacerbation - Bronchodilator<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
6\/13\/2024<\/td>2022<\/td>70731<\/td>Sutter Health Plus<\/td>Commercial <\/td>PCE - Pharmacotherapy Management of COPD Exacerbation - Systemic Corticosteroid<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
6\/9\/2024<\/td>2022<\/td>522756<\/td>Hamaspik Inc.<\/td>Medicare<\/td>UOP - Use of Opioids From Multiple Providers - Multiple Prescribers and Multiple Pharmacies<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
6\/8\/2024<\/td>2022<\/td>522756<\/td>Hamaspik Inc.<\/td>Medicare<\/td>UOP - Use of Opioids From Multiple Providers - Multiple Prescribers<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
6\/7\/2024<\/td>2022<\/td>522756<\/td>Hamaspik Inc.<\/td>Medicare<\/td>UOP - Use of Opioids From Multiple Providers - Multiple Pharmacies<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
6\/6\/2024<\/td>2022<\/td>522756<\/td>Hamaspik Inc.<\/td>Medicare<\/td>HDO - Use of Opioids at High Dosage<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
6\/9\/2024<\/td>2022<\/td>522756<\/td>Hamaspik Inc.<\/td>Medicare<\/td>HDO - Use of Opioids at High Dosage<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
5\/17\/2024<\/td>2022<\/td>285649<\/td>Molina Healthcare of New York, Inc.<\/td>Commercial <\/td>AAB - Avoidance of Antibiotic Treatment for Acute Bronchitis\/Bronchiolitis (Total)<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
5\/17\/2024<\/td>2022<\/td>285649<\/td>Molina Healthcare of New York, Inc.<\/td>Commercial <\/td>CWP - Appropriate Testing for Pharyngitis (Total)<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
5\/17\/2024<\/td>2022<\/td>285649<\/td>Molina Healthcare of New York, Inc.<\/td>Commercial <\/td>URI - Appropriate Treatment for Upper Respiratory Infection (Total)<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
4\/30\/2024<\/td>2022<\/td>127<\/td>Kaiser Foundation Health Plan of the Northwest, Inc.<\/td>Commercial <\/td>FUI- Follow-Up After High-Intensity Care for Substance Use Disorder - 30 Days (Total)<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
4\/30\/2024<\/td>2022<\/td>127<\/td>Kaiser Foundation Health Plan of the Northwest, Inc.<\/td>Commercial <\/td>FUI - Follow-Up After High-Intensity Care for Substance Use Disorder - 7 Days (Total)<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
4\/30\/2024<\/td>2022<\/td>127<\/td>Kaiser Foundation Health Plan of the Northwest, Inc.<\/td>Commercial <\/td>FUI - Follow-Up After High-Intensity Care for Substance Use Disorder - 30 Days (18-64)<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
4\/30\/2024<\/td>2022<\/td>127<\/td>Kaiser Foundation Health Plan of the Northwest, Inc.<\/td>Commercial <\/td>FUI - Follow-Up After High-Intensity Care for Substance Use Disorder - 7 Days (18-64)<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
4\/30\/2024<\/td>2022<\/td>127<\/td>Kaiser Foundation Health Plan of the Northwest, Inc.<\/td>Medicare<\/td>FUI - Follow-Up After High-Intensity Care for Substance Use Disorder - 30 days (Total)<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
4\/30\/2024<\/td>2022<\/td>127<\/td>Kaiser Foundation Health Plan of the Northwest, Inc.<\/td>Medicare<\/td>FUI - Follow-Up After High-Intensity Care for Substance Use Disorder - 7 Days (Total)<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
4\/30\/2024<\/td>2022<\/td>127<\/td>Kaiser Foundation Health Plan of the Northwest, Inc.<\/td>Medicare<\/td>FUI - Follow-Up After High-Intensity Care for Substance Use Disorder - 30 days (18-64)<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
4\/30\/2024<\/td>2022<\/td>127<\/td>Kaiser Foundation Health Plan of the Northwest, Inc.<\/td>Medicare<\/td>FUI - Follow-Up After High-Intensity Care for Substance Use Disorder - 7 Days (18-64)<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
4\/30\/2024<\/td>2022<\/td>127<\/td>Kaiser Foundation Health Plan of the Northwest, Inc.<\/td>Medicare<\/td>FUI - Follow-Up After High-Intensity Care for Substance Use Disorder - 30 days (65+)<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
4\/30\/2024<\/td>2022<\/td>127<\/td>Kaiser Foundation Health Plan of the Northwest, Inc.<\/td>Medicare<\/td>FUI - Follow-Up After High-Intensity Care for Substance Use Disorder - 7 Days (65+)<\/td>Erroneous logic resulted in under reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
3\/1\/2024<\/td>2022<\/td>1508<\/td>Security Health Plan of Wisconsin, Inc<\/td>Medicaid<\/td>Pharmacotherapy Management of COPD Exacerbation - Bronchodilator (PCE)<\/td>Erroneous logic resulted in underreporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
3\/1\/2024<\/td>2022<\/td>1508<\/td>Security Health Plan of Wisconsin, Inc<\/td>Medicaid<\/td>Pharmacotherapy Management of COPD Exacerbation - Systemic Corticosteroid (PCE)<\/td>Erroneous logic resulted in underreporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
3\/1\/2024<\/td>2022<\/td>1508<\/td>Security Health Plan of Wisconsin, Inc<\/td>Medicaid<\/td>Statin Therapy for Patients With Diabetes (SPD)<\/td>Erroneous logic resulted in underreporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
3\/1\/2024<\/td>2022<\/td>1508<\/td>Security Health Plan of Wisconsin, Inc<\/td>Medicaid<\/td>Follow-Up After Hospitalization For Mental Illness - 7 days (Total) (FUH)<\/td>Erroneous logic resulted in underreporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
3\/1\/2024<\/td>2022<\/td>1508<\/td>Security Health Plan of Wisconsin, Inc<\/td>Medicaid<\/td>Follow-Up After Hospitalization For Mental Illness - 7 days (18-64) (FUH)<\/td>Erroneous logic resulted in underreporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>144<\/td>CareFirst BlueChoice<\/td>Commercial <\/td>FUH -Follow-Up After Hospitalization For Mental Illness - 30 days (Total)<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>144<\/td>CareFirst BlueChoice<\/td>Commercial <\/td>FUH - Follow-Up After Hospitalization For Mental Illness - 7 days (Total)<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>144<\/td>CareFirst BlueChoice<\/td>Commercial <\/td>PRS-E - Prenatal Immunization Status - Influenza<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>144<\/td>CareFirst BlueChoice<\/td>Commercial <\/td>PRS-E - Prenatal Immunization Status - Combination <\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>144<\/td>CareFirst BlueChoice<\/td>Commercial <\/td>CIS - Childhood Immunization Status - Influenza<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>144<\/td>CareFirst BlueChoice<\/td>Commercial <\/td>IMA - Immunizations for Adolescents - Combination 1<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>144<\/td>CareFirst BlueChoice<\/td>Commercial <\/td>HBD - Hemoglobin A1c Control for Patients With Diabetes - HbA1c Control (<8%)<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>144<\/td>CareFirst BlueChoice<\/td>Commercial <\/td>EED - Eye Exam for Patients With Diabetes<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>144<\/td>CareFirst BlueChoice<\/td>Commercial <\/td>PPC - Prenatal and Postpartum Care - Timeliness of Prenatal Care<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>144<\/td>CareFirst BlueChoice<\/td>Commercial <\/td>CIS-E - Childhood Immunization Status - Influenza<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>144<\/td>CareFirst BlueChoice<\/td>Commercial <\/td>IMA-E - Immunizations for Adolescents - Combination 1<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>AMM - Antidepressant Medication Management - Effective Continuation Phase Treatment<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>ADD -Follow-Up Care for Children Prescribed ADHD Medication - Continuation and Maintenance Phase<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>FUH -Follow-Up After Hospitalization For Mental Illness - 30 days (Total)<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>FUH - Follow-Up After Hospitalization For Mental Illness - 7 days (Total)<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>FUA - Follow-Up After Emergency Department Visit for Substance Use - 30 days (Total)<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>FUA - Follow-Up After Emergency Department Visit for Substance Use - 7 days (Total)<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>APP - Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (Total)<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>ADD-E -Follow-Up Care for Children Prescribed ADHD Medication - Continuation and Maintenance Phase<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>CIS - Childhood Immunization Status - Diptheria, Tetanus, Acellular Pertussis<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>CIS - Childhood Immunization Status - Polio Vaccine<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>CIS - Childhood Immunization Status - Haemophilis Influenza Type B (HIB B)<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>CIS - Childhood Immunization Status - Pneumococcal Conjugate<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>CIS - Childhood Immunization Status - Rotavirus<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>HBD - Hemoglobin A1c Control for Patients With Diabetes - HbA1c Control (<8%)<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>BPD - Blood Pressure Control for Patients With Diabetes<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>EED - Eye Exam for Patients With Diabetes<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>PPC - Prenatal and Postpartum Care - Timeliness of Prenatal Care<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>CIS-E - Childhood Immunization Status - Diptheria, Tetanus, Acellular Pertussis<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>CIS-E - Childhood Immunization Status - Polio Vaccine<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>CIS-E - Childhood Immunization Status - Haemophilis Influenza Type B (HIB B)<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>CIS-E - Childhood Immunization Status - Pneumococcal Conjugate<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
1\/10\/2024<\/td>2022<\/td>1880<\/td>Group Hospitalization and Medical Services, Inc. (GHMSI)<\/td>Commercial <\/td>CIS-E - Childhood Immunization Status - Rotavirus<\/td>Erroneous logic resulted in over reporting of performance.<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
11\/27\/2023<\/td>2022<\/td>1800<\/td>Community Health Group<\/td>Medicaid<\/td>Follow-Up After Emergency Department Visit for Substance Use - 30 days (FUA)<\/td>Under reporting of denominator resulted in audit designation of NA instead of performance rate<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
11\/27\/2023<\/td>2022<\/td>1800<\/td>Community Health Group<\/td>Medicaid<\/td>Follow-Up After Emergency Department Visit for Substance Use - 7 days (FUA)<\/td>Under reporting of denominator resulted in audit designation of NA instead of performance rate<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
11\/27\/2023<\/td>2022<\/td>1800<\/td>Community Health Group<\/td>Medicaid<\/td>Follow-Up After High-Intensity Care for Substance Use Disorder - 30 Days (FUI)<\/td>Under reporting of denominator resulted in audit designation of NA instead of performance rate<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
11\/27\/2023<\/td>2022<\/td>1800<\/td>Community Health Group<\/td>Medicaid<\/td>Follow-Up After High-Intensity Care for Substance Use Disorder - 7 Days (FUI)<\/td>Under reporting of denominator resulted in audit designation of NA instead of performance rate<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
11\/27\/2023<\/td>2022<\/td>1800<\/td>Community Health Group<\/td>Medicaid<\/td>Initiation and Engagement of Substance Use Disorder Treatment - Initiation of SUD Treatment (IET)<\/td>Under reporting of denominator resulted in audit designation of NA instead of performance rate<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
11\/27\/2023<\/td>2022<\/td>1800<\/td>Community Health Group<\/td>Medicaid<\/td>Initiation and Engagement of Substance Use Disorder Treatment - Engagement of SUD Treatment (IET)<\/td>Under reporting of denominator resulted in audit designation of NA instead of performance rate<\/td>Due to assessed level of impact, no product updates were made.<\/td> <\/tr>\n
10\/12\/2023<\/td>2022<\/td>21588<\/td>Kansas Medicaid Health Plan (Sunflower Health Plan)<\/td>Medicaid<\/td>Risk of Continued Opioid Use ->=15 Days (65+) (COU)<\/td>Erroneous logic resulted in underreporting of performance.<\/td>Due to the assessed level of impact, no product updates were made.<\/td> <\/tr>\n <\/tbody>\n <\/table>\n \n \n \n<\/div>\n\n","protected":false},"excerpt":{"rendered":"

The data errata is a list of self-reported errors that were identified by organizations after the HEDIS data re-submission deadline of June 30th. Per NCQA’s HEDIS Volume 2, “organizations must immediately report any error in a measure rate or in its component (in any previous submission, regardless of timing) that is >5% higher or lower […]<\/p>\n","protected":false},"author":45,"featured_media":0,"parent":676,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page.php","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-26024","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nData Errata for HEDIS Data Submission - NCQA<\/title>\n<meta name=\"description\" content=\"Errors are reviewed by NCQA to assess the impact to NCQA products and programs, including but not limited to Health Plan Ratings, Quality Compass and Accreditation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ncqa.org\/hedis\/data-submission\/data-errata-for-hedis-data-submission\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Data Errata for HEDIS Data Submission - NCQA\" \/>\n<meta property=\"og:description\" content=\"Errors are reviewed by NCQA to assess the impact to NCQA products and programs, including but not limited to Health Plan Ratings, Quality Compass and Accreditation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ncqa.org\/hedis\/data-submission\/data-errata-for-hedis-data-submission\/\" \/>\n<meta property=\"og:site_name\" content=\"NCQA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/NCQA.org\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-29T16:33:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ncqa.org\/wp-content\/uploads\/2021\/04\/NCQA_cmyk_tag.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@NCQA\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ncqa.org\/hedis\/data-submission\/data-errata-for-hedis-data-submission\/\",\"url\":\"https:\/\/www.ncqa.org\/hedis\/data-submission\/data-errata-for-hedis-data-submission\/\",\"name\":\"Data Errata for HEDIS Data Submission - NCQA\",\"isPartOf\":{\"@id\":\"https:\/\/www.ncqa.org\/#website\"},\"datePublished\":\"2022-02-25T16:56:18+00:00\",\"dateModified\":\"2025-09-29T16:33:59+00:00\",\"description\":\"Errors are reviewed by NCQA to assess the impact to NCQA products and programs, including but not limited to Health Plan Ratings, Quality Compass and Accreditation.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ncqa.org\/hedis\/data-submission\/data-errata-for-hedis-data-submission\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ncqa.org\/hedis\/data-submission\/data-errata-for-hedis-data-submission\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ncqa.org\/hedis\/data-submission\/data-errata-for-hedis-data-submission\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ncqa.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HEDIS\",\"item\":\"https:\/\/www.ncqa.org\/hedis\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Data Submission\",\"item\":\"https:\/\/www.ncqa.org\/hedis\/data-submission\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Data Errata for HEDIS Data Submission\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ncqa.org\/#website\",\"url\":\"https:\/\/www.ncqa.org\/\",\"name\":\"NCQA\",\"description\":\"Measuring quality. Improving health care.\",\"publisher\":{\"@id\":\"https:\/\/www.ncqa.org\/#organization\"},\"alternateName\":\"National Committee for Quality Assurance\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ncqa.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ncqa.org\/#organization\",\"name\":\"NCQA\",\"alternateName\":\"National Committee for Quality Assurance\",\"url\":\"https:\/\/www.ncqa.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg\",\"contentUrl\":\"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg\",\"width\":876,\"height\":673,\"caption\":\"NCQA\"},\"image\":{\"@id\":\"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/NCQA.org\",\"https:\/\/x.com\/NCQA\",\"https:\/\/www.instagram.com\/ncqa_dc\/\",\"https:\/\/www.youtube.com\/@NcqaOrg\",\"https:\/\/www.linkedin.com\/company\/ncqa\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Data Errata for HEDIS Data Submission - NCQA","description":"Errors are reviewed by NCQA to assess the impact to NCQA products and programs, including but not limited to Health Plan Ratings, Quality Compass and Accreditation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ncqa.org\/hedis\/data-submission\/data-errata-for-hedis-data-submission\/","og_locale":"en_US","og_type":"article","og_title":"Data Errata for HEDIS Data Submission - NCQA","og_description":"Errors are reviewed by NCQA to assess the impact to NCQA products and programs, including but not limited to Health Plan Ratings, Quality Compass and Accreditation.","og_url":"https:\/\/www.ncqa.org\/hedis\/data-submission\/data-errata-for-hedis-data-submission\/","og_site_name":"NCQA","article_publisher":"https:\/\/www.facebook.com\/NCQA.org","article_modified_time":"2025-09-29T16:33:59+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.ncqa.org\/wp-content\/uploads\/2021\/04\/NCQA_cmyk_tag.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@NCQA","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ncqa.org\/hedis\/data-submission\/data-errata-for-hedis-data-submission\/","url":"https:\/\/www.ncqa.org\/hedis\/data-submission\/data-errata-for-hedis-data-submission\/","name":"Data Errata for HEDIS Data Submission - NCQA","isPartOf":{"@id":"https:\/\/www.ncqa.org\/#website"},"datePublished":"2022-02-25T16:56:18+00:00","dateModified":"2025-09-29T16:33:59+00:00","description":"Errors are reviewed by NCQA to assess the impact to NCQA products and programs, including but not limited to Health Plan Ratings, Quality Compass and Accreditation.","breadcrumb":{"@id":"https:\/\/www.ncqa.org\/hedis\/data-submission\/data-errata-for-hedis-data-submission\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ncqa.org\/hedis\/data-submission\/data-errata-for-hedis-data-submission\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ncqa.org\/hedis\/data-submission\/data-errata-for-hedis-data-submission\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ncqa.org\/"},{"@type":"ListItem","position":2,"name":"HEDIS","item":"https:\/\/www.ncqa.org\/hedis\/"},{"@type":"ListItem","position":3,"name":"Data Submission","item":"https:\/\/www.ncqa.org\/hedis\/data-submission\/"},{"@type":"ListItem","position":4,"name":"Data Errata for HEDIS Data Submission"}]},{"@type":"WebSite","@id":"https:\/\/www.ncqa.org\/#website","url":"https:\/\/www.ncqa.org\/","name":"NCQA","description":"Measuring quality. Improving health care.","publisher":{"@id":"https:\/\/www.ncqa.org\/#organization"},"alternateName":"National Committee for Quality Assurance","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ncqa.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ncqa.org\/#organization","name":"NCQA","alternateName":"National Committee for Quality Assurance","url":"https:\/\/www.ncqa.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg","contentUrl":"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg","width":876,"height":673,"caption":"NCQA"},"image":{"@id":"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/NCQA.org","https:\/\/x.com\/NCQA","https:\/\/www.instagram.com\/ncqa_dc\/","https:\/\/www.youtube.com\/@NcqaOrg","https:\/\/www.linkedin.com\/company\/ncqa\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages\/26024","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/users\/45"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/comments?post=26024"}],"version-history":[{"count":0,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages\/26024\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages\/676"}],"wp:attachment":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/media?parent=26024"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}